SAI LIFE SCIENCES LIMITED Fair Value
SAILIFE · Healthcare · Current price ₹1,517
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹123 | 15% ROE fading to 12% over ~3 yrs, on ₹117 book |
| Relative P/E | ₹645 | EPS × 39.1 peer-median P/E |
| Graham floor | ₹208 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,503 | Street consensus 12-month target price |
Is SAI LIFE SCIENCES LIMITED undervalued?
DocStoX estimates the fair value of SAI LIFE SCIENCES LIMITED at ₹502 per share, versus the current market price of ₹1,517. That puts the stock about -66.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹123), Relative P/E (₹645), Graham floor (₹208), Analyst target (₹1,503). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹123 (bear) to ₹502 (base) to ₹1,503 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SAI LIFE SCIENCES LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.